Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
‘Unsavoury’ Practices: Pharma Will Need To Be More Transparent On CME Expenses In India
Faces Audits Under Revised Rules
Apr 02 2024
•
By
Anju Ghangurde
India's revised code for pharma marketing practices outlines guidelines for CME programs • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from India
More from Asia